Avax Technologies Overview

  • Status
  • Public

  • Employees
  • 29

Employees
  • Stock Symbol
  • AVXT

Stock Symbol

Avax Technologies General Information

Description

Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
  • 2000 Hamilton Street
  • Philadelphia, PA 19130
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avax Technologies Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
22.3K

Avax Technologies Financials Summary

In Thousands,
USD
TTM 30-Sep-2008 FY 2007 31-Dec-2007 FY 2006 31-Dec-2006 FY 2005 31-Dec-2005
EV 6,073 8,358 6,035 8,860
Revenue 735 617 735 1,624
EBITDA (11,805) (6,113) (5,065) (3,389)
Net Income (7,378) (6,414) (5,356) (3,704)
Total Assets 1,367 7,377 3,044 7,348
Total Debt 362 325
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avax Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avax Technologies‘s full profile, request access.

Request a free trial

Avax Technologies Patents

Avax Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2006204896-A1 Method for producing a vaccine for the treatment of cancer Abandoned 14-Jan-2005 0000000000
CA-2593191-A1 Method for producing a vaccine for the treatment of cancer Abandoned 14-Jan-2005 0000000000
US-20130309271-A1 Method for producing a vaccine for the treatment of cancer Abandoned 14-Jan-2005 0000000000
US-20060240047-A1 Method for producing a vaccine for the treatment of cancer Abandoned 14-Jan-2005 0000000000 00
US-20100099187-A1 Method for producing a vaccine for the treatment of cancer Abandoned 14-Jan-2005 A61K39/385
To view Avax Technologies’s complete patent history, request access »

Avax Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial